Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Mounjaro was initially approved for diabetes, but tirzepatide now also has obesity-related approvals under separate branding
its about ensuring you fully understand how GLP-1 therapy works and how it fits into your overall treatment
Your prescriber uses your genetic profile alongside your clinical response to determine the most effective and efficient dosing pathway for your weight loss goals
In a recent study, weekly tirzepatide injections significantly reduced the risk of progression to Type 2 diabetes by 94% in adults with pre-diabetes and obesity compared to a placebo
Billing is monthly and injections only, verified at checkout July 2026
US$ 26.84
US$ 24.29
US$ 27.62
US$ 28.55
US$ 23.72
US$ 21.28
US$ 23.21
